Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04677166 · ClinicalTrials.gov registry record · NA

Coupling Negative Pressure Wound Therapy With Instillation

A NA study, sponsored by Loma Linda University.

Terminated
Registry status
NA
Development phase
6
Enrollment target

NCT04677166 is a NA study that was terminated before completion, run by Loma Linda University. The registered enrollment target is 6 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04677166, a NA study, was terminated before completion, sponsored by Loma Linda University.

TERMINATED
Registry status
NA
Development phase
6 participants
Enrollment target

Study Summary

The objective of this study is to compare standard negative pressure wound therapy with negative pressure wound therapy coupled with instillation for optimal skin graft take. Either the V.A.C ULTA NPWT or V.A.C. VeraFlo Therapy systems with normal saline will be applied intra-operatively to split-thickness skin grafts of upper and lower extremity wounds and kept in place for a duration of four days. Following completion of four days, the skin graft with be assessed for percentage of take/adherence and will be covered with simple gauze dressings as needed.

Interventions

  • DEVICE Negative pressure wound therapy coupled with instillation
  • DEVICE Standard Negative Pressure Wound Therapy

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2021-01-19
Est. Completion 2024-10-21
Phase NA

Sponsor

Loma Linda University

237 total trials

What the Registry Record Tells You About NCT04677166

The ClinicalTrials.gov registry entry for NCT04677166 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Loma Linda University, which has 237 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Negative pressure wound therapy coupled with instillation is the first listed.

NCT04677166 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04677166 about?

NCT04677166 is a clinical study titled "Coupling Negative Pressure Wound Therapy With Instillation". The objective of this study is to compare standard negative pressure wound therapy with negative pressure wound therapy coupled with instillation for optimal skin graft take. Either the V.A.C ULTA NPWT or V.A.C. VeraFlo Therapy systems with normal saline will be applied intra-operatively to split-th...

What is the current status of trial NCT04677166?

This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2021-01-19. Estimated completion is 2024-10-21.

What interventions are being tested in trial NCT04677166?

The interventions under investigation include: Negative pressure wound therapy coupled with instillation (DEVICE), Standard Negative Pressure Wound Therapy (DEVICE).

Who is sponsoring clinical trial NCT04677166?

This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.